Biogen Needs Revenue-Generating Assets to Complete Turnaround, Wedbush Says

Biogen (BIIB) needs to acquire additional revenue-generating assets for the turnaround to complete, Wedbush said in a Tuesday note to clients.The company has indicated capacity for $8 billion to $10

MT Newswires35minutes ago

Viridian, Pharvaris Said to Be Among Prime M&A Targets for Biogen

Seeking Alpha52minutes ago

Biogen's Strategic Acquisitions and Growth Potential: An Analyst's Hold Rating Justification

TipRanksJul 16 07:05 ET

Goldman Sachs Adjusts Price Target on Biogen to $342 From $340, Maintains Buy Rating

Biogen (BIIB) has an average outperform rating and a price target range of $200 to $350, according to analysts polled by Capital IQ.Price: 222.01, Change: +0.43, Percent Change: +0.19

MT NewswiresJul 16 06:24 ET

Jeito Capital Consolidates Its Support in CatalYm With a Renewed Participation in a $150 Million Financing

Jeito Capital consolidates its support in CatalYm with a renewed participation in a $150 million financing

GlobeNewswireJul 16 05:10 ET

Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'

Sen. Bernie Sanders (I-Vt.) recently expressed his concerns about the high cost of medical care in the United States, highlighting the financial burden it places on patients.

BenzingaJul 15 21:36 ET